Parallel reports
- Each domain is reported separately.
- Integration depends on individual time and expertise.
- Discordances may remain unnoticed.
- Value often ends when the result is delivered.
AXIS for specialty laboratories
Your laboratory generates the data - AXIS reveals how they relate.
AXIS provides the deterministic architecture for connecting blood, fecal microbiota, urine biomarkers and metabolomics, genetics and other source families. It turns separate results into a structured, explainable professional product through within-domain patterns and cross-patterns—without replacing the analytical laboratory report.
01 / From reports to an ecosystem
More testing does not automatically create more understanding.
A laboratory can measure with extraordinary precision and still deliver disconnected outputs. AXIS structures relationships within each source family and across panels, assays and biological domains.
Interpretive ecosystem
- Domains retain their identity and become connected.
- Within-domain patterns and cross-patterns are processed through reproducible logic.
- Convergences, discordances and potential interactions become explicit.
- The catalogue becomes a reusable product platform.
02 / Deterministic architecture
AXIS does not generate a summary - It executes a governed inference chain.
The same input, processed by the same version, produces the same output. Every result retains a reverse path to the source data, including activated rules, coverage, confidence and conflicts.
InputsBlood, fecal microbiota, metabolomics, genetics, wearables and authorized context are linked to one episode.Retains: original value · unit · date · provenance
Normalized parametersEach measurement receives a canonical identity, comparable unit and module-specific SIR.Produces: comparable signals without losing source data
Domain patternsExplicit rules combine related parameters within the same biological data family.Evaluates: activation · coverage · confidence · coherence
Cross-patternsThey relate concordant or discordant signals across sources when defined by the governed module.Example: blood ↔ fecal microbiota ↔ metabolomics
Blocks & axesPatterns are organized into functional blocks and higher-order dimensions of biological state.Retains: contribution · redundancy · conflicts
Traceable outputDBSI, axes, confidence and trajectory remain connected to the rules and measurements that generated them.Result: explainable · reproducible · auditable
03 / Illustrative biointegrative case
An isolated result informs - Cross-patterns reveal how results relate.
This conceptual scenario demonstrates multimodal and cross-pattern product logic. It does not represent a patient, validated configuration or clinical conclusion.
Five source families · one biological question
Are the observed shifts independent, or do they form a coherent biological configuration?
BloodInflammatory and metabolic shift
Fecal microbiotaReduced mucosal and ecosystem resilience
Urine biomarkers / metabolomicsIncreased oxidative and metabolic demand
GeneticsContext relevant to methylation and current phenotype
Wearables / contextRecovery, sleep, intervention and timing context
Cross-domain inflammatory amplificationIndependent domains support the same functional direction.
Mucosal–metabolic interactionThe intestinal signal adds context to the systemic metabolic pattern.
Increasing compensatory demandApparent stability may require a more intense biological response.
Genetic context with current expressionGenetic information is interpreted alongside observed phenotype, never in isolation.
Structured output
AXIS organizes within-domain patterns, cross-patterns, convergence, discordance, coverage and confidence for professional review; it does not diagnose from this scenario.
04 / Laboratory advantage
A new product layer over the catalogue you already own.
The laboratory retains its tests, methods and relationships. AXIS turns the relationships between them into a differentiated and scalable capability.
01 · New product
Premium professional reporting
A structured, traceable synthesis that can accompany a defined panel or multimodal package.
02 · Scale
API, white-label and longitudinal use
Integrate outputs into portals, clinic workflows and recurring programs.
03 · Learning
Real-world evidence foundation
Versioned states make retrospective evaluation and new hypotheses more feasible.
04 · Efficiency
Less repetitive manual integration
Known relationships are structured automatically; professional attention is reserved for exceptions.
05 · Differentiation
A catalogue that operates as a system
Connect proprietary panels without becoming another testing provider.
06 · Positioning
Commercial expansion
Move from measurement to interpretation under a governed framework.
05 / Pilot contract
One panel - One population - One professional workflow.
A serious pilot removes ambiguity at the input, model, output and evaluation levels.
| Contract | Purpose | Typical content |
|---|---|---|
| Input contract | What enters the model. | One panel, selected metadata and optional supplementary data families. |
| Model contract | How the module behaves. | Rules, intended users, exclusions, confidence logic and version. |
| Output contract | What the partner receives. | Report, JSON/API, portal layer or white-label package. |
| Evaluation contract | How success is assessed. | Scientific fit, workflow value, turnaround and commercial relevance. |
06 / Ownership clarity
Collaborate without diluting either party’s assets.
The final contract must define data, development, validation, use and rights from the outset.
Tests, data relationships and market position
- Assays, methods and analytical results
- Client and professional relationships
- Data under the agreed legal framework
- Brand and proprietary laboratory assets
Core architecture and pre-existing know-how
- Deterministic Core and general architecture
- Libraries, rules, thresholds and know-how
- Pre-existing code, tools and configurations
- General improvements unless expressly agreed otherwise
Current status
The deterministic infrastructure is available. The multimodal biointegrative configuration is in development. Professional utility must be demonstrated through retrospective or supervised evaluation, and any medical pathway depends on the final intended use and jurisdiction.
Laboratory partnership
Build the first verifiable multimodal laboratory product.
Start with a panel or package that already has market relevance and a professional workflow that can be evaluated clearly.